Literature DB >> 9809403

Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa.

M Nagl1, B Pfausler, E Schmutzhard, M Fille, W Gottardi.   

Abstract

N-chlorotaurine, a weak antimicrobial oxidant produced by stimulated human leukocytes, was used to treat cystitis caused by an omniresistant Pseudomonas aeruginosa. A 21-year-old male patient was treated by repeated daily lavages of the urinary bladder with an aqueous solution of 1% N-chlorotaurine for one month. N-chlorotaurine was well tolerated; no local or systemic side effects could be detected. Despite killing of > 10(6) cfu/ml of bacteria within ten minutes in vitro and in vivo, it was not possible to eradicate the Pseudomonas infection obviously caused by inflammation of the upper urinary tract and perpetuated by intravesical concrements. Nevertheless, in actually localized infection, treatment with N-chlorotaurine might be successful because of its sufficient bactericidal action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809403     DOI: 10.1016/s0934-8840(98)80043-1

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  11 in total

1.  Effect of N-chlorotaurine mouth rinses on plaque regrowth and plaque vitality.

Authors:  K Lorenz; D Mayer; G Bruhn; B Noack; M Brecx; C Heumann; H Toutenburg; L Netuschil; M Nagl; W Gottardi; T Hoffmann
Journal:  Clin Oral Investig       Date:  2008-06-27       Impact factor: 3.573

2.  Inactivation of Adenovirus in Water by Natural and Synthetic Compounds.

Authors:  Lucas Ariel Totaro Garcia; Laurita Boff; Célia Regina Monte Barardi; Markus Nagl
Journal:  Food Environ Virol       Date:  2019-02-04       Impact factor: 2.778

Review 3.  N-chloramines, a promising class of well-tolerated topical anti-infectives.

Authors:  Waldemar Gottardi; Dmitri Debabov; Markus Nagl
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  Bactericidal and Fungicidal Activity of N-Chlorotaurine Is Enhanced in Cystic Fibrosis Sputum Medium.

Authors:  Martina Gruber; Ivan Moser; Markus Nagl; Michaela Lackner
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 5.  Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases.

Authors:  Janusz Marcinkiewicz; Markus Nagl; Anthony Kyriakopoulos; Maria Walczewska; Magdalena Skóra; Paulina Skalska
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  Taurine modulates neutrophil function but potentiates uropathogenic E. coli infection in the murine bladder.

Authors:  Claire Condron; Rowan G Casey; Siobhan Kehoe; Deirdre Toomey; Tom Creagh; David J Bouchier-Hayes
Journal:  Urol Res       Date:  2009-11-26

7.  Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye--a phase 1 clinical study.

Authors:  Barbara Teuchner; Eduard Schmid; Hanno Ulmer; Waldemar Gottardi; Markus Nagl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-12       Impact factor: 3.117

8.  Cytotoxic activity of N-chlorotaurine on Acanthamoeba spp.

Authors:  Ursula Fürnkranz; Markus Nagl; Waldemar Gottardi; Martina Köhsler; Horst Aspöck; Julia Walochnik
Journal:  Antimicrob Agents Chemother       Date:  2007-11-26       Impact factor: 5.191

9.  Bactericidal activity of N-chlorotaurine against biofilm-forming bacteria grown on metal disks.

Authors:  Débora C Coraça-Huber; Christoph G Ammann; Manfred Fille; Johann Hausdorfer; Michael Nogler; Markus Nagl
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

10.  N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.

Authors:  Michaela Lackner; Ulrike Binder; Martin Reindl; Beyhan Gönül; Hannes Fankhauser; Christian Mair; Markus Nagl
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.